Ueki M, Yokono S, Ogli K
J Anesth. 2013; 9(1):65-9.
PMID: 23839838
DOI: 10.1007/BF02482039.
Price L, Wort S, Finney S, Marino P, Brett S
Crit Care. 2010; 14(5):R169.
PMID: 20858239
PMC: 3219266.
DOI: 10.1186/cc9264.
LAVER M
World J Surg. 1983; 7(1):31-41.
PMID: 6837063
DOI: 10.1007/BF01655910.
Hoffman M, Greenfield L, Sugerman H, Tatum J
Ann Surg. 1983; 198(3):307-19.
PMID: 6615053
PMC: 1353298.
DOI: 10.1097/00000658-198309000-00007.
Schulz V, Schnabel K, Schmidt W
Klin Wochenschr. 1974; 52(13):624-30.
PMID: 4849541
DOI: 10.1007/BF01468797.
Energy metabolism in sepsis: treatment based on different patterns in shock and high output stage.
CLOWES Jr G, ODonnell Jr T, Ryan N, Blackburn G
Ann Surg. 1974; 179(5):684-96.
PMID: 4823845
PMC: 1356054.
DOI: 10.1097/00000658-197405000-00023.
[Pathophysiological aspects of circulation and respiration in life-threatening infections (septic shock)].
Thimme W, DISSMANN W, Buschmann H, Daugs J, Eisele R, Ramdohr B
Klin Wochenschr. 1972; 50(14):674-88.
PMID: 4561055
DOI: 10.1007/BF01495526.
A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance.
Parrillo J, BURCH C, Shelhamer J, Parker M, Natanson C, Schuette W
J Clin Invest. 1985; 76(4):1539-53.
PMID: 4056039
PMC: 424125.
DOI: 10.1172/JCI112135.
Gram-negative bacteremia produces both severe systolic and diastolic cardiac dysfunction in a canine model that simulates human septic shock.
Natanson C, Fink M, Ballantyne H, MacVittie T, Conklin J, Parrillo J
J Clin Invest. 1986; 78(1):259-70.
PMID: 3722379
PMC: 329557.
DOI: 10.1172/JCI112559.
Right ventricular dysfunction in patients with septic shock.
Dhainaut J, Lanore J, De Gournay J, Huyghebaert M, Brunet F, Villemant D
Intensive Care Med. 1988; 14 Suppl 2:488-91.
PMID: 3403793
DOI: 10.1007/BF00256967.
Right ventricular function in septic shock.
Reuse C, Frank N, Contempre B, Vincent J
Intensive Care Med. 1988; 14 Suppl 2:486-7.
PMID: 3403792
DOI: 10.1007/BF00256966.
Peripheral vascular resistance in septic shock: its relation to outcome.
Groeneveld A, Nauta J, Thijs L
Intensive Care Med. 1988; 14(2):141-7.
PMID: 3361019
DOI: 10.1007/BF00257468.
The influence of catecholamines on right ventricular function in septic shock.
Schreuder W, Schneider A, Groeneveld A, Thijs L
Intensive Care Med. 1988; 14 Suppl 2:492-5.
PMID: 3042832
DOI: 10.1007/BF00256968.
Role of endotoxemia in cardiovascular dysfunction and mortality. Escherichia coli and Staphylococcus aureus challenges in a canine model of human septic shock.
Natanson C, Danner R, Elin R, Hosseini J, Peart K, Banks S
J Clin Invest. 1989; 83(1):243-51.
PMID: 2642920
PMC: 303668.
DOI: 10.1172/JCI113866.
Effect of Escherichia coli lipopolysaccharide on phosphatidylcholine biosynthesis by rat lung and alveolar type II cells.
Bosch M, Risco C
Mol Cell Biochem. 1990; 93(2):167-72.
PMID: 2189066
DOI: 10.1007/BF00226188.
[Cardiorespiratory problems in intensive care (author's transl)].
LAVER M
Langenbecks Arch Chir. 1976; 342:331-40.
PMID: 994652
DOI: 10.1007/BF01267392.
Cardiopulmonary effects of volume loading in patients in septic shock.
Krausz M, Perel A, Eimerl D, Cotev S
Ann Surg. 1977; 185(4):429-34.
PMID: 843138
PMC: 1396139.
DOI: 10.1097/00000658-197704000-00010.
Sepsis, resuscitated hemorrhagic shock and "shock lung:" An experimental correlation.
Esrig B, Fulton R
Ann Surg. 1975; 182(3):218-27.
PMID: 240329
PMC: 1343928.
DOI: 10.1097/00000658-197509000-00005.
Septic lung and shock lung in man.
CLOWES Jr G, Hirsch E, Williams L, Kwasnik E, ODonnell T, Cuevas P
Ann Surg. 1975; 181(5):681-92.
PMID: 236738
PMC: 1345566.
DOI: 10.1097/00000658-197505000-00024.